Progress and Clinical Applications of Crohn’s Disease Exclusion Diet in Crohn’s Disease Duo Xu, Ziheng Peng, Yong Li, Qian Hou, Yu Peng, Xiaowei Liu Gut and Liver.2024; 18(3): 404. CrossRef
Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw Journal of Gastroenterology and Hepatology.2023; 38(4): 523. CrossRef
Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea Sang Hyoung Park, Jong Pil Im, Hyunju Park, Seung Kyu Jeong, Ji Hyun Lee, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Joo Sung Kim, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O Journal of Crohn's and Colitis.2022; 16(2): 207. CrossRef
Use of Complementary and Alternative Medicine by Greek Patients with Inflammatory Bowel Disease John K. Triantafillidis, Aristofanis Gikas, Georgia Kontrarou, Manousos Konstantoulakis, Apostolos Papalois Nutrients.2024; 16(21): 3679. CrossRef
Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD) Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi Expert Review of Clinical Pharmacology.2021; 14(7): 865. CrossRef
Patients with Crohn’s disease (CD) commonly develop bowel strictures, which may contain various degrees of inflammation and fibrosis. While predominantly inflammatory strictures may benefit from a medical anti-inflammatory treatment approach, fibrotic strictures would require endoscopic balloon dilation or surgery. Cross-sectional imaging surpasses endoscopy for characterization of stenotic segments and potentially may contribute to the optimal clinical management of these patients. This short review aims to discuss the potentialities and limitations of cross-sectional imaging techniques for assessing bowel fibrosis in patients with CD.
Citations
Citations to this article as recorded by
Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the AJR Special Series on Imaging of Fibrosis Jordi Rimola, Kim J. Beek, Ingrid Ordás, Krisztina B. Gecse, Míriam Cuatrecasas, Jaap Stoker American Journal of Roentgenology.2024;[Epub] CrossRef
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, Alex Bastianelli, Valerio Fulci, Alessandra Renzini, Giusy Russo, Salvatore Oliva, Roberta Vitali, Francesca Palone, Salvatore Cucchiara, Laura Stronati Inflammation Research.2024; 73(8): 1359. CrossRef
Crohn's-like Ileal Pouch Illness and Ileal Pouch Salvage Strategies Alex L. Huang, Marnie Abeshouse, Katherine C. Lee, Emily Rinebold, Maia Kayal, Michael C. Plietz Clinics in Colon and Rectal Surgery.2024;[Epub] CrossRef
Quantitative Magnetic Resonance Imaging (qMRI) of the Small Bowel in Crohn's Disease: State‐of‐the‐Art and Future Directions Naomi S. Sakai, Timothy J.P. Bray, Stuart A. Taylor Journal of Magnetic Resonance Imaging.2024;[Epub] CrossRef
Invasive Therapeutic Strategies for Stricturing Crohn’s Disease in Childhood: A Systematic Review and Meta-Analysis Matheus Ferreira de Carvalho, Alexandre de Sousa Carlos, Angelo So Taa Kum, Alexandre Moraes Bestetti, Igor Logetto Caetité Gomes, Luiza Bicudo de Oliveira, Luiza Martins Baroni, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura Inflammatory Bowel Diseases.2024;[Epub] CrossRef
Inhibition of intestinal inflammation and fibrosis by Scutellaria Baicalensis georgi and Boswellia serrata in human epithelial cells and fibroblasts Ilaria Laudadio, Beatrice Leter, Francesca Palone, Salvatore Cucchiara, Claudia Carissimi, Noemi Scafa, Daniela Secci, Roberta Vitali, Laura Stronati Immunity, Inflammation and Disease.2024;[Epub] CrossRef
Elastography as a Discriminator Between Fibrotic and Inflammatory Strictures in Crohn’s Disease: A Dead End or Bright Future in Clinical Decision-Making? Critical Review Maryla Kuczyńska, Monika Zbroja, Anna Drelich-Zbroja Diagnostics.2024; 14(20): 2299. CrossRef
Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling Huimin Yu, Zixin Zhang, Gangping Li, Yan Feng, Lingling Xian, Fatemeh Bakhsh, Dongqing Xu, Cheng Xu, Tyrus Vong, Bin Wu, Florin M. Selaru, Fengyi Wan, Mark Donowitz, G. William Wong Cellular and Molecular Gastroenterology and Hepatology.2023; 15(4): 1000. CrossRef
Frequency, outcomes, and need for intervention in stricturing gastrointestinal tuberculosis: a systematic review and meta-analysis Anuraag Jena, Ritin Mohindra, Kirtan Rana, Pardhu B. Neelam, Dhuni Chand Thakur, Harjeet Singh, Pankaj Gupta, Vikas Suri, Vishal Sharma BMC Gastroenterology.2023;[Epub] CrossRef
Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn’s Disease: Are We There Yet? Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel Ross Van Langenberg Diagnostics.2023; 13(6): 1061. CrossRef
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi Journal of Clinical Medicine.2023; 12(9): 3052. CrossRef
Intestinal MRI in Inflammatory Bowel Disease – Literature and Survey-Based Recommendations regarding Reporting by the German Radiological Society (DRG) and the German Competence Network for Inflammatory Bowel Diseases Johannes Wessling, Torsten Kucharzik, Dominik Bettenworth, Andreas Luegering, Christian Maaser, Lars Grenacher, Markus S. Juchems, Kristina I. Ringe, Thomas Lauenstein, Andreas G. Schreyer RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2023; 195(08): 675. CrossRef
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence? Sara Jarmakiewicz-Czaja, Aneta Sokal, Katarzyna Ferenc, Elżbieta Motyka, Kacper Helma, Rafał Filip Genes.2023; 14(6): 1167. CrossRef
The Role of Magnetic Resonance Enterography for Detection and Differentiation of Pediatric Inflammatory Bowel Diseases Eda ALMUS, Özge YAPICI Genel Tıp Dergisi.2023; 33(6): 726. CrossRef
Revisiting fibrosis in inflammatory bowel disease: the gut thickens Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169. CrossRef
Ultrasound elastography Xin-Wu Cui, Kang-Ning Li, Ai-Jiao Yi, Bin Wang, Qi Wei, Ge-Ge Wu, Christoph F. Dietrich Endoscopic Ultrasound.2022; 11(4): 252. CrossRef
ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jo Journal of Crohn's and Colitis.2022; 16(4): 523. CrossRef
Positionspapier zur Befunderhebung von Darmultraschallbefunden bei chronisch entzündlichen Darmerkrankungen Torsten Kucharzik, Raja Atreya, Oliver Bachmann, Daniel C. Baumgart, Jan Daebritz, Ulf Helwig, Johannes Janschek, Peter Kienle, Jost Langhorst, Jonas Mudter, Carsten Schmidt, Andreas G. Schreyer, Michael Vieth, Johannes Wessling, Christian Maaser Zeitschrift für Gastroenterologie.2022; 60(06): 978. CrossRef
Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye? Joseph Sleiman, Prathyush Chirra, Namita S. Gandhi, Mark E. Baker, Cathy Lu, Ilyssa O. Gordon, Satish E. Viswanath, Florian Rieder United European Gastroenterology Journal.2022; 10(10): 1167. CrossRef
Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker, Florian Rieder Expert Review of Gastroenterology & Hepatology.2021; 15(4): 401. CrossRef
Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease Muaad Abdulla, Thean Soon Chew Current Opinion in Gastroenterology.2021; 37(3): 275. CrossRef
Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype Helena Tavares de Sousa, Irene Gullo, Claudia Castelli, Cláudia Camila Dias, Florian Rieder, Fátima Carneiro, Fernando Magro Clinical and Translational Gastroenterology.2021; 12(4): e00330. CrossRef
Intestinal stricture in Crohn's disease: A 2020 update Xiao Xuan Lin, Yun Qiu, Xiao Jun Zhuang, Fen Liu, Xiao Min Wu, Min Hu Chen, Ren Mao Journal of Digestive Diseases.2021; 22(7): 390. CrossRef
Crohn’s disease at radiological imaging: focus on techniques and intestinal tract Giuseppe Cicero, Silvio Mazziotti Intestinal Research.2021; 19(4): 365. CrossRef
Mechanism of fibrosis and stricture formation in Crohn's disease Johannes Alfredsson, Mary Jo Wick Scandinavian Journal of Immunology.2020;[Epub] CrossRef
The specific pathogenesis underlining inflammatory bowel disease (IBD) is very complicated, and it is further more difficult to clearly explain the pathophysiology of 2 major forms of IBD, Crohn’s disease (CD) and ulcerative colitis (UC), and both disorders affect individuals throughout life. Despite every extensive effort, the interplay among genetic factors, immunological factors, environmental factors and intestinal microbes is still completely unrevealed. Animal models are indispensable to find out mechanistic details that will facilitate better preclinical setting to target specific components involved in the pathogenesis of IBD. Based on many recent reports, dysbiosis of the commensal microbiota is implicated in the pathogenesis of several diseases, not only IBD but also colon cancer, obesity, psoriasis as well as allergic disorders, in both human and animal models. Advanced technologies including cell-specific and inducible knockout systems, which are recently employed to mouse IBD models, have further enhanced the ability of developing new therapeutic strategies for IBD. Furthermore, data from these mouse models highlight the critical involvement of dysregulated immune responses and impaired colonic epithelial defense system in the pathogenesis of IBD. In this review, we will explain from the history of animal models of IBD to the recent reports of the latest compounds, therapeutic strategies, and approaches tested on IBD animal models.
Citations
Citations to this article as recorded by
Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea Young-Eun Kim, Ye-Jee Kim, Dae Hyun Jeong, Seonok Kim, Min Jee Kim, Hyeon Hwa Kim, Kyung-Wook Jo, Sang Hyoung Park, Seokchan Hong Seminars in Arthritis and Rheumatism.2024; 65: 152362. CrossRef
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model Chunhua Yang, Didier Merlin Inflammatory Bowel Diseases.2024; 30(5): 844. CrossRef
An evaluation of animal models for using bioactive compounds in the treatment of inflammatory bowel disease Shanshan Tie, Yannan Chen, Mingqian Tan Food Frontiers.2024; 5(2): 474. CrossRef
Approaches, Strategies and Procedures for Identifying Anti-Inflammatory Drug Lead Molecules from Natural Products Tenzin Jamtsho, Karma Yeshi, Matthew J. Perry, Alex Loukas, Phurpa Wangchuk Pharmaceuticals.2024; 17(3): 283. CrossRef
Protective Effect of Perilla Seed Meal and Perilla Seed Extract against Dextran Sulfate Sodium-Induced Ulcerative Colitis through Suppressing Inflammatory Cytokines in Mice Natticha Sumneang, Komsak Pintha, Sarawut Kongkarnka, Maitree Suttajit, Napapan Kangwan Molecules.2024; 29(9): 1940. CrossRef
Sacroiliitis in inflammatory bowel disease on abdominal computed tomography: prevalence, misses, and associated factors DK Kim, K-C Lee, JK Kim Scandinavian Journal of Rheumatology.2024; 53(4): 248. CrossRef
Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation Qiaoling Sun, Heng Li, Jing Lv, Weilin Shi, Yanfeng Bai, Ke Pan, Alice Chen Cellular Immunology.2024; 401-402: 104839. CrossRef
Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention Hong Huang, Gejing Li, Yini He, Jing Chen, Jianye Yan, Qin Zhang, Liqing Li, Xiong Cai Frontiers in Immunology.2024;[Epub] CrossRef
Advances in Vascular Diagnostics using Magnetic Particle Imaging (MPI) for Blood Circulation Assessment Marisa O Pacheco, Isabelle K Gerzenshtein, Whitney L Stoppel, Carlos M Rinaldi‐Ramos Advanced Healthcare Materials.2024;[Epub] CrossRef
Modelling the innate immune system in microphysiological systems Michael J. Rupar, Hannah Hanson, Stephanie Rogers, Brianna Botlick, Steven Trimmer, James J. Hickman Lab on a Chip.2024; 24(15): 3604. CrossRef
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering Oliver Sandys, Pieter C. F. Stokkers, Anje A. te Velde Digestive Diseases and Sciences.2024;[Epub] CrossRef
Bioinspired and bioderived nanomedicine for inflammatory bowel disease Rafaela Gazzi, Rita Gelli, Simone Aleandri, Marianna Carone, Paola Luciani WIREs Nanomedicine and Nanobiotechnology.2024;[Epub] CrossRef
Target potential of miRNAs in ulcerative colitis: what do we know? Peeyush Kumar, Saurabh Kedia, Vineet Ahuja Expert Opinion on Therapeutic Targets.2024; : 1. CrossRef
Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease Rucha Chandwaskar, Rajdeep Dalal, Saurabh Gupta, Aishwarya Sharma, Deepak Parashar, Vivek K. Kashyap, Jagdip Singh Sohal, Subhash K. Tripathi Scandinavian Journal of Immunology.2024;[Epub] CrossRef
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, Andrea Galli, Gabriele Dragoni Inflammatory Bowel Diseases.2023; 29(2): 308. CrossRef
Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4+ T Cells Ameliorates Intestinal Inflammation Hoyul Lee, Jae Han Jeon, Yu-Jeong Lee, Mi-Jin Kim, Woong Hee Kwon, Dipanjan Chanda, Themis Thoudam, Haushabhau S. Pagire, Suvarna H. Pagire, Jin Hee Ahn, Robert A. Harris, Eun Soo Kim, In-Kyu Lee Cellular and Molecular Gastroenterology and Hepatology.2023; 15(2): 439. CrossRef
Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, Byong Duk Ye, Kyeong Ok Kim, Jeong Eun Shin, Yong Sik Yoon, Hong Sub Lee, Sung Hoon Jung, Miyoung Choi, Soo-Young Na, Chang Hwan Choi, Joo Sung Kim Intestinal Research.2023; 21(1): 43. CrossRef
Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls Min Heo, Young Soo Park, Hyuk Yoon, Nam-Eun Kim, Kangjin Kim, Cheol Min Shin, Nayoung Kim, Dong Ho Lee Gut and Liver.2023; 17(1): 108. CrossRef
Therapeutic Potential of Bioactive Components from Scutellaria baicalensis Georgi in Inflammatory Bowel Disease and Colorectal Cancer: A Review Jung Yoon Jang, Eunok Im, Nam Deuk Kim International Journal of Molecular Sciences.2023; 24(3): 1954. CrossRef
Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study Joo Kyung Kim, Jae Hee Cheon Journal of Yeungnam Medical Science.2023; 40(1): 37. CrossRef
Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi Intestinal Research.2023; 21(1): 148. CrossRef
miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases? Ioanna Aggeletopoulou, Athanasia Mouzaki, Konstantinos Thomopoulos, Christos Triantos International Journal of Molecular Sciences.2023; 24(3): 2233. CrossRef
Succinate metabolism and its regulation of host-microbe interactions Yi-han Wei, Xi Ma, Jiang-chao Zhao, Xiu-qi Wang, Chun-qi Gao Gut Microbes.2023;[Epub] CrossRef
A westernized diet changed the colonic bacterial composition and metabolite concentration in a dextran sulfate sodium pig model for ulcerative colitis Farhad M. Panah, Katrine D. Nielsen, Gavin L. Simpson, Anna Schönherz, Andreas Schramm, Charlotte Lauridsen, Tina S. Nielsen, Ole Højberg, Marlene Fredborg, Stig Purup, Nuria Canibe Frontiers in Microbiology.2023;[Epub] CrossRef
pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential Jacek Stalewski, Amy Y. Shih, Romeo Papazyan, Jocelyn Ramirez, Gerardo Ibanez, Peng Hsiao, Yong Yue, Jun Yin, Calen Badger, Shije Wu, Akemi Ueki, Bryan C. Fuchs, Marie-Laure Rives Journal of Pharmacology and Experimental Therapeutics.2023; 386(1): 35. CrossRef
The Relationship Between Rosacea and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Yu Kyung Jun, Da-Ae Yu, Yoo Min Han, Soo Ran Lee, Seong-Joon Koh, Hyunsun Park Dermatology and Therapy.2023; 13(7): 1465. CrossRef
Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022 Cuilan Huang, Wujuan Hao, Xuyang Wang, Renmin Zhou, Qiong Lin Frontiers in Microbiology.2023;[Epub] CrossRef
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279 Silvana Leit, Jeremy Greenwood, Samantha Carriero, Sayan Mondal, Robert Abel, Mark Ashwell, Heather Blanchette, Nicholas A. Boyles, Mark Cartwright, Alan Collis, Shulu Feng, Phani Ghanakota, Geraldine C. Harriman, Vinayak Hosagrahara, Neelu Kaila, Rosanna Journal of Medicinal Chemistry.2023; 66(15): 10473. CrossRef
Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function Jae-Young Lee, Hyun Woo Ma, Ji Hyung Kim, I Seul Park, Mijeong Son, Keun Ho Ryu, Jieun Shin, Seung Won Kim, Jae Hee Cheon Gut and Liver.2023; 17(5): 766. CrossRef
Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease Kwang Woo Kim, Hyoun Woo Kang Intestinal Research.2023; 21(4): 413. CrossRef
Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn’s Disease Seung Won Kim, Jae-Young Lee, Han Cheol Lee, Jae Bum Ahn, Ji Hyung Kim, I Seul Park, Jae Hee Cheon, Duk Hwan Kim Gut and Liver.2023; 17(6): 905. CrossRef
Immortalized Canine Adipose-Derived Mesenchymal Stem Cells Maintain the Immunomodulatory Capacity of the Original Primary Cells Yuyo Yasumura, Takahiro Teshima, Tomokazu Nagashima, Masaki Michishita, Takashi Takano, Yoshiaki Taira, Ryohei Suzuki, Hirotaka Matsumoto International Journal of Molecular Sciences.2023; 24(24): 17484. CrossRef
Animal models of inflammatory bowel disease: category and evaluation indexes Changlin Wen, Dan Chen, Rao Zhong, Xi Peng Gastroenterology Report.2023;[Epub] CrossRef
Recent development in zebrafish model for bioactivity and safety evaluation of natural products Fang-Jun Lin, Hang Li, Ding-Tao Wu, Qi-Guo Zhuang, Hua-Bin Li, Fang Geng, Ren-You Gan Critical Reviews in Food Science and Nutrition.2022; 62(31): 8646. CrossRef
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis Makoto Naganuma, Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Toshiyuki Matsui, Yasuo Suzuki, Lyann Ursos, Shigeru Sakamoto, Mitsuhiro Shikamura, Tetsuharu Hori, Jovelle Fernandez, Mamoru Watanabe, Toshifumi Hibi, Takanori Kanai Journal of Gastroenterology and Hepatology.2022; 37(1): 81. CrossRef
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1 Agustin Casimiro-Garcia, Christophe Allais, Agnes Brennan, Chulho Choi, Gabriela Dower, Kathleen A. Farley, Margaret Fleming, Andrew Flick, Richard K. Frisbie, Justin Hall, David Hepworth, Hannah Jones, John D. Knafels, Steve Kortum, Frank E. Lovering, Jo Journal of Medicinal Chemistry.2022; 65(1): 757. CrossRef
Copper oxide nanoparticles synthesized from Trichosanthes kirilowii ameliorates the DSS-induced acute colitis in mice through the suppression of inflammatory responses Xuefeng Jiang, Yu Sun, Tahani Awad Alahmadi, Velu Manikandan, Thamaraiselvan Rengarajan, Yuyang Zhao Journal of King Saud University - Science.2022; 34(3): 101817. CrossRef
Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation 雅君 陈 Hans Journal of Food and Nutrition Science.2022; 11(01): 44. CrossRef
Jianpi Qingchang Decoction Ameliorates Chronic Colitis in Piroxicam-Induced IL-10 Knockout Mice by Inhibiting Endoplasmic Reticulum Stress Qian Chen, Ya-Li Zhang, Zi-Wei Zhang, Yu-Jun Chen, Ying-Jue Tang, Dan Qiao, Yan-Cheng Dai, Zhi-Peng Tang, Lu sa Mota da Silva Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1. CrossRef
Reactive Oxygen Species-Responsive Polyether Micelle Nanomaterials for Targeted Treatment of Ulcerative Colitis Xin-Xin Zhao, Shan-Bo Ma, Jin-Peng Wen, Da-Tao Hu, Ju-Shan Gao, Qiao Peng, Yu-Chen Zhang, Jin-Qing Wang, Ke Wang, Xiao-Peng Shi Journal of Biomedical Nanotechnology.2022; 18(1): 120. CrossRef
Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1 Olga Hartwig, Brigitta Loretz, Adrien Nougarede, Dorothée Jary, Eric Sulpice, Xavier Gidrol, Fabrice Navarro, Claus-Michael Lehr Journal of Controlled Release.2022; 345: 646. CrossRef
Asymptomatic sacroiliitis detected by magnetic resonance enterography in patients with Crohn's disease: prevalence, association with clinical data, and reliability among radiologists in a multicenter study of adult and pediatric population Lorenzo Cereser, Giovanni Zancan, Ivan Giovannini, Carmelo Cicciò, Ilaria Tinazzi, Angela Variola, Matteo Bramuzzo, Flora Maria Murru, Marco Marino, Annarita Tullio, Salvatore De Vita, Rossano Girometti, Alen Zabotti Clinical Rheumatology.2022; 41(8): 2499. CrossRef
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now? Sang Hyoung Park Intestinal Research.2022; 20(2): 159. CrossRef
Polysaccharides from soybean residue fermented by Neurospora crassa alleviate DSS-induced gut barrier damage and microbiota disturbance in mice Wenli Huang, Zeyuan Deng, Ling Lu, Yaoming Ouyang, Shuyuan Zhong, Ting Luo, Yawei Fan, Liufeng Zheng Food & Function.2022; 13(10): 5739. CrossRef
Mesenchymal stem cell treatment for enteric neuropathy in the Winnie mouse model of spontaneous chronic colitis Ainsley M. Robinson, Rhian Stavely, Sarah Miller, Rajaraman Eri, Kulmira Nurgali Cell and Tissue Research.2022; 389(1): 41. CrossRef
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence Jongwook Yu, Hye Kyung Hyun, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon Gut and Liver.2022; 16(3): 414. CrossRef
Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway Se Lim Kim, Min Woo Shin, Seung Young Seo, Sang Wook Kim Bioscience Reports.2022;[Epub] CrossRef
Ulcerative Colitis and Patient’s Quality of Life, Especially in Early Stage Jung Won Lee Gut and Liver.2022; 16(3): 317. CrossRef
Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function Mijeong Son, I Seul Park, Soochan Kim, Hyun Woo Ma, Ji Hyung Kim, Tae Il Kim, Won Ho Kim, Jaeyong Han, Seung Won Kim, Jae Hee Cheon Frontiers in Immunology.2022;[Epub] CrossRef
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs) Xue Yuan, Yong Chen, Minghai Tang, Yuhan Wei, Mingsong Shi, Yingxue Yang, Yanting Zhou, Tao Yang, Jiang Liu, Kongjun Liu, Dexin Deng, Chufeng Zhang, Lijuan Chen Journal of Medicinal Chemistry.2022; 65(13): 9312. CrossRef
Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study Su Young Kim, Yeon Seo Cho, Hyun-Soo Kim, Jung Kuk Lee, Hee Man Kim, Hong Jun Park, Hyunil Kim, Jihoon Kim, Dae Ryong Kang Gut and Liver.2022; 16(4): 555. CrossRef
The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn’s Disease Seung Yong Shin, Sounkou Kim, Ji Won Choi, Sang-Bum Kang, Tae Oh Kim, Geom Seog Seo, Jae Myung Cha, Jaeyoung Chun, Yunho Jung, Jong Pil Im, Ki Bae Bang, Chang Hwan Choi, Soo-Kyung Park, Dong Il Park Microorganisms.2022; 10(7): 1467. CrossRef
Medication Adherence in Korean Patients with Inflammatory Bowel
Disease and Its Associated Factors Kyunghwan Oh, Eun Ja Kwon, Jeong Hye Kim, Kyuwon Kim, Jae Yong Lee, Hee Seung Hong, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jeong Yun Park, Sang Hyoung Park The Ewha Medical Journal.2022; 45(2): 35. CrossRef
Inflammatory bowel disease in Korea: epidemiology and pathophysiology Jung Won Lee, Chang Soo Eun The Korean Journal of Internal Medicine.2022; 37(5): 885. CrossRef
Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs Soo-Young Na, You Sun Kim The Korean Journal of Internal Medicine.2022; 37(5): 906. CrossRef
Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis Jae Song Kim, Min Jung Geum, Eun Sun Son, Yun Mi Yu, Jae Hee Cheon, Kyeng Hee Kwon Gut and Liver.2022; 16(5): 736. CrossRef
Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea Gi-Ung Kang, Sowon Park, Yeongyun Jung, Jai J. Jee, Min-Sueng Kim, Seungjun Lee, Dong-Woo Lee, Jae-Ho Shin, Hong Koh Gut and Liver.2022; 16(5): 775. CrossRef
Clinical applications and optimization of patient-derived organoids in intestinal diseases Tae Il Kim Organoid.2022; 2: e22. CrossRef
Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge Gut and Liver.2022; 16(6): 907. CrossRef
Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study Sowon Park, Ben Kang, Seung Kim, Sujin Choi, Hyo Rim Suh, Eun Sil Kim, Ji Hyung Park, Mi Jin Kim, Yon Ho Choe, Yeoun Joo Lee, Jae Hong Park, Eell Ryoo, Hong Koh, Byung-Ho Choe Gut and Liver.2022; 16(6): 921. CrossRef
Class III phosphatidylinositol 3-kinase complex I subunit NRBF2/Atg38 - from cell and structural biology to health and disease Yohei Ohashi Autophagy.2021; 17(12): 3897. CrossRef
Prevention of dextran sulfate sodium-induced mouse colitis by the fungal protein Ling Zhi-8viapromoting the barrier function of intestinal epithelial cells Yu-Huan Chen, Jenn-Yeu Shin, Hsiu-Mei Wei, Chi-Chien Lin, Linda C. H. Yu, Wei-Ting Liao, Dz-Chi Chen, Ching-Liang Chu Food & Function.2021; 12(4): 1639. CrossRef
Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome Sonia Marinho, Matilde Illanes, Javier Ávila-Román, Virginia Motilva, Elena Talero Biomolecules.2021; 11(2): 162. CrossRef
Discovery of 3-(4-(2-((1H-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease Chufeng Zhang, Wenyan Qi, Yong Li, Minghai Tang, Tao Yang, Kongjun Liu, Yong Chen, Dexin Deng, Mingli Xiang, Lijuan Chen Journal of Medicinal Chemistry.2021; 64(4): 1966. CrossRef
Modeling microbe-host interaction in the pathogenesis of Crohn’s disease Mohamed Ahmed, Amira Metwaly, Dirk Haller International Journal of Medical Microbiology.2021; 311(3): 151489. CrossRef
Therapeutic Effects of Probiotic Minas Frescal Cheese on the Attenuation of Ulcerative Colitis in a Murine Model Bárbara F. Cordeiro, Juliana L. Alves, Giovanna A. Belo, Emiliano R. Oliveira, Marina P. Braga, Sara H. da Silva, Luisa Lemos, Jonas T. Guimarães, Ramon Silva, Ramon S. Rocha, Gwénaël Jan, Yves Le Loir, Marcia Cristina Silva, Mônica Q. Freitas, Erick A. E Frontiers in Microbiology.2021;[Epub] CrossRef
Increased Interleukin-10 Expression by the Inhibition of Ca2+-Activated K+ Channel KCa3.1 in CD4+CD25+ Regulatory T Cells in the Recovery Phase in an Inflammatory Bowel Disease Mouse Model Susumu Ohya, Miki Matsui, Junko Kajikuri, Kyoko Endo, Hiroaki Kito Journal of Pharmacology and Experimental Therapeutics.2021; 377(1): 75. CrossRef
Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn’s disease You-Jung Ha, Hyo Jin Kim, Eugene Lee, Ji Hye Park, Young Soo Park, Yun Jong Lee, Yusuhn Kang, Hyuk Yoon The Korean Journal of Internal Medicine.2021; 36(4): 868. CrossRef
Epithelial Regeneration Ability of Crohn’s Disease Assessed Using Patient-Derived Intestinal Organoids Chansu Lee, Sung-Noh Hong, Eun-Ran Kim, Dong-Kyung Chang, Young-Ho Kim International Journal of Molecular Sciences.2021; 22(11): 6013. CrossRef
Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD Olga Hartwig, Maryam A. Shetab Boushehri, Karim S. Shalaby, Brigitta Loretz, Alf Lamprecht, Claus-Michael Lehr Advanced Drug Delivery Reviews.2021; 175: 113828. CrossRef
Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational stud Min Young Park, Yong Sik Yoon, Jong Lyul Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Chang Sik Yu Stem Cell Research & Therapy.2021;[Epub] CrossRef
Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes Andrés Hurtado-Lorenzo, Gerard Honig, Sarah Alandra Weaver, Paul B Larkin, Caren Heller Crohn's & Colitis 360.2021;[Epub] CrossRef
Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice Sushmita Negi, Sheetal Saini, Nikunj Tandel, Kiran Sahu, Ravi P.N. Mishra, Rajeev K. Tyagi Cells.2021; 10(8): 1847. CrossRef
Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice I Seul Park, Mijeong Son, Hyun Woo Ma, Jihyung Kim, Da Hye Kim, Seung Won Kim, Jae Hee Cheon Intestinal Research.2021; 19(3): 349. CrossRef
Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies Hyo Yeop Song, Geom Seog Seo Journal of the Korean Medical Association.2021; 64(9): 605. CrossRef
Intestinal microbiota and inflammatory bowel diseases Chang Soo Eun Journal of the Korean Medical Association.2021; 64(9): 588. CrossRef
Expression of Th17/Treg Cells in Peripheral Blood and Related Cytokines of Patients with Ulcerative Colitis of Different Syndrome Types and Correlation with the Disease Jianhua Yu, Shu Wang, Hongsheng Yuan, Tingyue Qiao, Miao Bao, Songwen Tan Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1. CrossRef
Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases Mercedes Lopez-Santalla, Marina Inmaculada Garin Biomedicines.2021; 9(11): 1507. CrossRef
EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE Kamila Rosa MARTINS, Joniel Mendes de ARAÚJO, Álefe Cardoso CRUZ, Anderson LUIZ-FERREIRA Arquivos de Gastroenterologia.2021; 58(3): 377. CrossRef
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon Intestinal Research.2021; 19(4): 478. CrossRef
Biological Analyses-Derived Translational Findings in the T Cell Receptor Alpha Chain Knockout Mouse as an Experimental Model for Ulcerative Colitis Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada International Journal of Translational Medicine.2021; 1(3): 187. CrossRef
The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability Sarah Stiegeler, Kevin Mercurio, Miruna Alexandra Iancu, Sinéad C. Corr Cells.2021; 10(12): 3358. CrossRef
The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Min Zou, Qi-Shan Zeng, Jiao Nie, Jia-Hui Yang, Zhen-Yi Luo, Hua-Tian Gan Frontiers in Immunology.2021;[Epub] CrossRef
Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review Ji Young Chang, Jae Hee Cheon Precision and Future Medicine.2021; 5(4): 151. CrossRef
Genetics and epigenetics of IBD Vito Annese Pharmacological Research.2020; 159: 104892. CrossRef
Secondary causes of inflammatory bowel diseases Yezaz A Ghouri, Veysel Tahan, Bo Shen World Journal of Gastroenterology.2020; 26(28): 3998. CrossRef
High‐dose dietary supplementation with zinc prevents gut inflammation: Investigation of the role of metallothioneins and beyond by transcriptomic and metagenomic studies Benoît Foligné, Fanny George, Annie Standaert, Anne Garat, Sabine Poiret, Véronique Peucelle, Stéphanie Ferreira, Hélène Sobry, Ghaffar Muharram, Anca Lucau‐Danila, Catherine Daniel The FASEB Journal.2020; 34(9): 12615. CrossRef
Colorectal cancer (CRC) is among the most common malignancies and remains a major cause of cancer-related death worldwide. Despite recent advances in surgical and multimodal therapies, the overall survival of advanced CRC patients remains very low. Cancer progression, including invasion and metastasis, is a major cause of death among CRC patients. The underlying mechanisms of action resulting in cancer progression are beginning to unravel. The reported molecular and biochemical mechanisms that might contribute to the phenotypic changes in favor of carcinogenesis include apoptosis inhibition, enhanced tumor cell proliferation, increased invasiveness, cell adhesion perturbations, angiogenesis promotion, and immune surveillance inhibition. These events may contribute to the development and progression of cancer. A biomarker is a molecule that can be detected in tissue, blood, or stool samples to allow the identification of pathological conditions such as cancer. Thus, it would be beneficial to identify reliable and practical molecular biomarkers that aid in the diagnostic and therapeutic processes of CRC. Recent research has targeted the development of biomarkers that aid in the early diagnosis and prognostic stratification of CRC. Despite that, the identification of diagnostic, prognostic, and/or predictive biomarkers remains challenging, and previously identified biomarkers might be insufficient to be clinically applicable or offer high patient acceptability. Here, we discuss recent advances in the development of molecular biomarkers for their potential usefulness in early and less-invasive diagnosis, treatment, and follow-up of CRC.
Citations
Citations to this article as recorded by
Anti‐angiogenesis in colorectal cancer therapy Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, Xiaonan Xi, Wentian Liu, Weilong Zhong Cancer Science.2024; 115(3): 734. CrossRef
Bioinformatics analysis of markers based on m6A related to prognosis combined with immune invasion of rectal adenocarcinoma Shunkang Yan, Jiandong Zhang, Lianghe Li, Gang Chen, Zhongsheng Chen, Wei Zhan Cancer Biomarkers.2024; 40(1): 95. CrossRef
Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis Shan Li, Ting Li, Yan-Qing Shi, Bin-Jie Xu, Yu-Yong Deng, Xu-Guang Sun Cancer Biomarkers.2024; 40(1): 27. CrossRef
Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer Ashkan Hajjafari, Soheil Sadr, Abbas Rahdar, Mansour Bayat, Narges Lotfalizadeh, Shiva Dianaty, Arezou Rezaei, Soroush Partovi Moghaddam, Khashayar Hajjafari, Pouria Ahmadi Simab, Zelal Kharaba, Hassan Borji, Sadanand Pandey Inorganic Chemistry Communications.2024; 164: 112409. CrossRef
The potential role of SNHG16/ miRNA-146a/ TRAF6 signaling pathway in the protective effect of zoledronate against colorectal cancer and associated osteoporosis in mouse model Amany Helmy Mohamed, Ahmed Noureldin Hassan, Nesma Hussein Abdel hay, Manar Fouad Ahmed, Marwa M. El Sawy, Mohamed M. Sonbol, Reham Hussein Mohamed International Immunopharmacology.2024; 133: 112125. CrossRef
An Updated Review on Molecular Biomarkers in Diagnosis and Therapy
of Colorectal Cancer Shruthi Nagainallur Ravichandran, Makalakshmi Murali Kumar, Alakesh Das, Antara Banerjee, Suhanya Veronica, Alexander Sun-Zhang, Hong Zhang, Muralidharan Anbalagan, Xiao-Feng Sun, Surajit Pathak Current Cancer Drug Targets.2024; 24(6): 595. CrossRef
Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer Danique J. I. Heuvelings, Anne G. W. E. Wintjens, Laura Moonen, Sanne M. E. Engelen, Ignace H. J. T. de Hingh, Liselot B. Valkenburg-van Iersel, Marcel den Dulk, Jan Beckervordersandforth, Sharon G. M. Thijssen, Daphne J. G. Leunissen, Laurents P. S. Stas International Journal of Molecular Sciences.2023; 24(16): 12830. CrossRef
A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery Iqbal Jalaludin, David M. Lubman, Jeongkwon Kim Mass Spectrometry Reviews.2023; 42(2): 844. CrossRef
Comment on " Positive fecal immunochemical test results are associated with non-colorectal cancer mortality" Yong Eun Park The Korean Journal of Internal Medicine.2023; 38(2): 264. CrossRef
Simple Isothermal and Label-Free Strategy for Colorectal Cancer Potential Biomarker miR-625-5p Detection Yifei Chen, Lizhen Ye, Hui Chen, Tingting Fan, Cheng Qiu, Yan Chen, Yuyang Jiang Biosensors.2023; 13(1): 78. CrossRef
DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review Danique J. I. Heuvelings, Anne G. W. E. Wintjens, Julien Luyten, Guus E. W. A. Wilmink, Laura Moonen, Ernst-Jan M. Speel, Ignace H. J. T. de Hingh, Nicole D. Bouvy, Andrea Peeters Cancers.2023; 15(2): 549. CrossRef
The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer Xiao Meng Pei, Heong Ting Wong, Simon Siu Man Ng, Wing Wa Leung, Yee Ni Wong, Hin Fung Tsang, Amanda Kit Ching Chan, Yin Kwan Evelyn Wong, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, William Chi Shing Cho, John Kwok Cheung Chan, Kwong Fai Wong, John M Luk, W Expert Review of Molecular Diagnostics.2023; 23(2): 171. CrossRef
lncRNA HCG11 Promotes Colorectal Cancer Cell Malignant Behaviors via Sponging miR-26b-5p Song Guo, Bingtan Song, Lin Li, Hesheng Li, Tao Yang, Lianmeng Cao, Jian Wang, Fu Wang Journal of Immunology Research.2023; 2023: 1. CrossRef
Ferroptosis open a new door for colorectal cancer treatment Hong Liang, Xia He, Yitong Tong, Niuniu Bai, Yushu Pu, Ke Han, Yi Wang Frontiers in Oncology.2023;[Epub] CrossRef
Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer Huafeng Jiang, Senjun Zhou, Gang Li Frontiers in Pharmacology.2023;[Epub] CrossRef
Polymeric nanoparticles approach and identification and characterization of novel biomarkers for colon cancer Devesh u kapoor, Rahul Garg, Mansi Gaur, Bhupendra G. Prajapati, Gyan Agrawal, Sankha Bhattacharya, Gehan M. Elossaily Results in Chemistry.2023; 6: 101167. CrossRef
Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis Ki-Hyun Kim, Young-Lan Park, Sun-Young Park, Young-Eun Joo Pathology - Research and Practice.2023; 251: 154875. CrossRef
Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review Nefeli Giannopoulou, Constantina Constantinou Oncology.2023; 101(10): 675. CrossRef
Diagnostic value of serum procalcitonin and C-reactive protein in discriminating between bacterial and nonbacterial colitis: a retrospective study Jae Yong Lee, So Yeon Lee, Yoo Jin Lee, Jin Wook Lee, Jeong Seok Kim, Ju Yup Lee, Byoung Kuk Jang, Woo Jin Chung, Kwang Bum Cho, Jae Seok Hwang Journal of Yeungnam Medical Science.2023; 40(4): 388. CrossRef
ZNF746 plays cardinal roles on colorectal cancer (CRC) cell invasion and migration and regulates mitochondrial dynamics and morphological changes of CRC cells—Role of combined melatonin and 5‐FU regimen Chi‐Ruei Huang, Yu‐Ting Chu, Chia‐Lo Chang, Hon‐Kan Yip, Hong‐Hwa Chen Journal of Cellular Biochemistry.2023;[Epub] CrossRef
IDENTIFICATION AND FUNCTIONAL ANALYSIS OF microRNA AS PROSPECTIVE PROGNOSTIC MARKERS OF COLORECTAL CANCER S.V. Maliborska, T.V. Zadvornyi Oncology.2023; 25(3): 207. CrossRef
PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer Akira Koshino, Aya Nagano, Akinobu Ota, Toshinori Hyodo, Akane Ueki, Masayuki Komura, Akane Sugimura-Nagata, Masahide Ebi, Naotaka Ogasawara, Kenji Kasai, Yoshitaka Hosokawa, Kunio Kasugai, Satoru Takahashi, Shingo Inaguma Frontiers in Pharmacology.2022;[Epub] CrossRef
Medicina de precisión: rol de la anatomía patológica en diagnóstico y tratamiento personalizado Tania S. Quiroz, Facundo Las Heras Revista Médica Clínica Las Condes.2022; 33(1): 36. CrossRef
Immune profile by multiplexed immunohistochemistry associated with recurrence after chemoradiation in rectal cancer Seung Wook Hong, Seohyun Lee, Yun Jae Kim, Soyeon Ahn, In Ja Park, Seung‐Mo Hong, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Suk‐Kyun Yang, Jaeil Kim, Sang‐Yeob Kim, Seung‐Jae Myung Journal of Gastroenterology and Hepatology.2022; 37(3): 542. CrossRef
SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer Akane Sugimura-Nagata, Akira Koshino, Kazuhiro Nagao, Aya Nagano, Masayuki Komura, Akane Ueki, Masahide Ebi, Naotaka Ogasawara, Toyonori Tsuzuki, Kenji Kasai, Satoru Takahashi, Kunio Kasugai, Shingo Inaguma International Journal of Molecular Sciences.2022; 23(5): 2753. CrossRef
Osteoporosis Is Associated with an Increased Risk of Colorectal Adenoma and High-Risk Adenoma: A Retrospective, Multicenter, Cross-Sectional, Case-Control Study Ji Hyung Nam, Myung Koh, Hyoun Woo Kang, Kum Hei Ryu, Dong Seok Lee, Su Hwan Kim, Dong Kee Jang, Ji Bong Jeong, Ji Won Kim, Kook Lae Lee, Dong Jun Oh, Yun Jeong Lim, Seong-Joon Koh, Jong Pil Im, Joo Sung Kim Gut and Liver.2022; 16(2): 269. CrossRef
The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer Kazuhiro Nagao, Akira Koshino, Akane Sugimura-Nagata, Aya Nagano, Masayuki Komura, Akane Ueki, Masahide Ebi, Naotaka Ogasawara, Toyonori Tsuzuki, Kenji Kasai, Satoru Takahashi, Kunio Kasugai, Shingo Inaguma International Journal of Molecular Sciences.2022; 23(6): 3252. CrossRef
Risk of Metachronous Colorectal Advanced Neoplasia and Cancer in Patients With 3–4 Nonadvanced Adenomas at Index Colonoscopy: A Systematic Review and Meta-Analysis Suyeon Park, Seong Ran Jeon, Hyun Gun Kim, Yunho Jung, Min-Seob Kwak, Su Young Kim, Jong Wook Kim, Seung-Joo Nam, Eun Hye Oh, Seon-Young Park, Soo-Kyung Park, Jeong-Sik Byeon, Sun-Jin Boo, Dong Hoon Baek, Soon Man Yoon, Jaeyoung Chun, Jooyoung Lee, Miyoun American Journal of Gastroenterology.2022; 117(4): 588. CrossRef
MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer Matthew G. Davey, Gerard Feeney, Heidi Annuk, Maxwell Paganga, Emma Holian, Aoife J. Lowery, Michael J. Kerin, Nicola Miller Cancers.2022; 14(9): 2109. CrossRef
Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer Joyeon Kang, Doyeon Lee, Kyoung Jin Lee, Jaepil Eric Yoon, Ji-Hee Kwon, Yoojeong Seo, Janghyun Kim, Shin Young Chang, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim Cancers.2022; 14(12): 2881. CrossRef
The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer Dexin Shen, Hongwei Peng, Caixia Xia, Zhao Deng, Xi Tong, Gang Wang, Kaiyu Qian Frontiers in Molecular Biosciences.2022;[Epub] CrossRef
New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer Cristiana Caliceti, Angela Punzo, Alessia Silla, Patrizia Simoni, Giulia Roda, Silvana Hrelia Nutrients.2022; 14(14): 2964. CrossRef
An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer Pouria Samadi, Meysam Soleimani, Fatemeh Nouri, Fatemeh Rahbarizadeh, Rezvan Najafi, Akram Jalali BMC Cancer.2022;[Epub] CrossRef
Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer Namjoo Kim, Jeong-An Gim, Beom Jae Lee, Byung il Choi, Hee Sook Yoon, Seung Han Kim, Moon Kyung Joo, Jong-Jae Park, Chungyeul Kim Scientific Reports.2022;[Epub] CrossRef
LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS Qing Chen, Lin Zhou, De Ma, Juan Hou, Yuxin Lin, Jie Wu, Min Tao Journal of Translational Medicine.2022;[Epub] CrossRef
Associations of C‑X‑C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer Xiaofan Luo, Jiandong Tai, Yuhang Zhao, Pingwei Zhao, Di Sun, Lei Wang Oncology Letters.2022;[Epub] CrossRef
Artificial intelligence-based colorectal polyp histology prediction using narrow-band image-magnifying colonoscopy: a stepping stone for clinical practice Ji Young Chang Clinical Endoscopy.2022; 55(5): 699. CrossRef
Clinical applications and optimization of patient-derived organoids in intestinal diseases Tae Il Kim Organoid.2022; 2: e22. CrossRef
Novel laboratory biomarkers in colorectal cancer management Marija Gegovska, Marija Hiljadnikova-Bajro Macedonian Pharmaceutical Bulletin.2022; 68(03): 333. CrossRef
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer Anil K. Giri Frontiers in Pharmacology.2021;[Epub] CrossRef
Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease Natalia Diaz-Garrido, Cecilia Cordero, Yenifer Olivo-Martinez, Josefa Badia, Laura Baldomà International Journal of Molecular Sciences.2021; 22(4): 2213. CrossRef
High phospho‐histone H3 expression uniquely predicts favorable survival among four markers of cellular proliferation in colorectal cancer Akira Koshino, Satoshi Inoue, Akane Sugimura‐Nagata, Takeshi Nishiyama, Hideki Murakami, Hideaki Ito, Miho Riku, Akihito Inoko, Masahide Ebi, Naotaka Ogasawara, Toyonori Tsuzuki, Kunio Kasugai, Kenji Kasai, Shingo Inaguma Pathology International.2021; 71(5): 316. CrossRef
Editorial Comment on High phospho‐histone H3 expression uniquely predicts favorable survival among four markers of cellular proliferation in colorectal cancer Hiroshi Kijima Pathology International.2021; 71(5): 325. CrossRef
Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma Hyunsung Kim, Seungyun Jee, Yeseul Kim, Jongmin Sim, Seongsik Bang, Hwang Kyu Son, Hosub Park, Jaekyung Myung, Young Hyeh Ko, Seung Sam Paik Diagnostics.2021; 11(4): 668. CrossRef
A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer Young-Lan Park, Sun-Young Park, Hyung-Hoon Oh, Min-Woo Chung, Ji-Yun Hong, Ki-Hyun Kim, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Hyun-Soo Kim, Young-Eun Joo Cancers.2021; 13(8): 1927. CrossRef
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab Samantha Epistolio, Marco Cefalì, Paolo Spina, Francesca Molinari, Alessandra Movilia, Massimiliano Cergnul, Luca Mazzucchelli, Sara De Dosso, Milo Frattini, Piercarlo Saletti Oncotarget.2021; 12(11): 1046. CrossRef
Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity Yoonsuk Jung, Eui Im, Jinhee Lee, Hyeah Lee, Changmo Moon Journal of Personalized Medicine.2021; 11(6): 497. CrossRef
Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients Wei Zhang, Liewen Lin, Ligang Xia, Wanxia Cai, Weier Dai, Chang Zou, Lianghong Yin, Donge Tang, Yong Xu, Yong Dai Journal of Translational Medicine.2021;[Epub] CrossRef
High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer Fahimeh Fattahi, Leili Saeednejad Zanjani, Zohreh Habibi Shams, Jafar Kiani, Mitra Mehrazma, Mohammad Najafi, Zahra Madjd Scientific Reports.2021;[Epub] CrossRef
Predictors of clinical outcomes of self-expandable metal stent treatment for malignant colorectal obstruction Bora Han, Ji-Yun Hong, Eun Myung, Hyung-Hoon Oh, Hee-Chan Yang, Sang-Wook Kim, Jun Lee, Seong-Jung Kim, Yeom-Dong Han, Geom-Seok Seo, Gun-Young Hong, Ho-Dong Kim, Hyun-Soo Kim, Young-Eun Joo Medicine.2021; 100(27): e26616. CrossRef
Risk-stratified colorectal cancer screening for optimal use of colonoscopy resources Dong-Hoon Yang The Korean Journal of Internal Medicine.2021; 36(4): 839. CrossRef
LncRNA AFAP1-AS1 Promotes the Progression of Colorectal Cancer through miR-195-5p and WISP1 Yongsheng Li, Zhongpeng Zhu, Xiaokun Hou, Yongjun Sun, Muhammad Wasim Khan Journal of Oncology.2021; 2021: 1. CrossRef
RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls Namjoo Kim, Jeong-An Gim, Beom Jae Lee, Byung il Choi, Seung Bin Park, Hee Sook Yoon, Sang Hee Kang, Seung Han Kim, Moon Kyung Joo, Jong-Jae Park, Chungyeul Kim, Han-Kyeom Kim Functional & Integrative Genomics.2021; 21(3-4): 513. CrossRef
Overview of serum and tissue markers in colorectal cancer: a primer for radiologists Apurva Bonde, Daniel A. Smith, Elias Kikano, Jennifer M. Yoest, Sree H. Tirumani, Nikhil H. Ramaiya Abdominal Radiology.2021; 46(12): 5521. CrossRef
Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRC Huisheng Liu, JiaYuan Zhong, JiaQi Hu, ChongYin Han, Rui Li, XueQing Yao, ShiPing Liu, Pei Chen, Rui Liu, Fei Ling Molecular Therapy - Oncolytics.2021; 22: 495. CrossRef
Faecal Diagnostic Biomarkers for Colorectal Cancer Andrea Cruz, Carla M. Carvalho, Alexandra Cunha, Anais Crespo, Águeda Iglesias, Laura García-Nimo, Paulo P. Freitas, Joaquín Cubiella Cancers.2021; 13(21): 5568. CrossRef
Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis Tao Wang, Jiandong Fei, Shuangfa Nie, Ajay Goel PLOS ONE.2021; 16(11): e0260035. CrossRef
Detection of Microsatellite Instability in Colorectal Cancer Patients With a Plasma-Based Real-Time PCR Analysis Namjoo Kim, Sung Min Kim, Beom Jae Lee, Byung il Choi, Hee Sook Yoon, Sang Hee Kang, Seung Han Kim, Moon Kyung Joo, Jong-Jae Park, Chungyeul Kim Frontiers in Pharmacology.2021;[Epub] CrossRef
Identification of Whole-Serum Glycobiomarkers for Colorectal Carcinoma Using Reverse-Phase Lectin Microarray Tomas Bertok, Aniko Bertokova, Eduard Jane, Michal Hires, Juvissan Aguedo, Maria Potocarova, Ludovit Lukac, Alica Vikartovska, Peter Kasak, Lubor Borsig, Jan Tkac Frontiers in Oncology.2021;[Epub] CrossRef
LncRNA PTTG3P Sponge Absorbs microRNA-155-5P to Promote Metastasis of Colorectal Cancer
Ning Liu, Lei Dou, Xinxin Zhang OncoTargets and Therapy.2020; Volume 13: 5283. CrossRef
Background/Aims Exclusive enteral nutrition (EEN) is recommended for induction of remission in pediatric Crohn’s disease (CD). However, it is not currently recommended for inducing remission in adults. This report describes the use of 12-week EEN for induction of remission in anti-tumor necrosis factor (anti-TNF) refractory adult CD.
Methods This is a retrospective analysis of adults with moderate to severe active (Crohn’s Disease Activity Index [CDAI] >220) anti-TNF refractory CD, who received EEN for 12 weeks between April 2018 and March 2019 at Dayanand Medical College and Hospital, Ludhiana, India. Primary outcomes included achievement of clinical remission and fistula healing at 12 weeks. Improvement in inflammatory markers and nutritional status were the secondary end points.
Results Out of 23 patients who received anti-TNF agents, 7 (30.4%) were refractory and were offered EEN as a salvage therapy. Six patients (66.7% females, mean age 25.6±6.5 years) consented. Four patients (66.6%) achieved clinical remission (CDAI <150). Mean CDAI of patients decreased significantly after 12 weeks of EEN (388.8±74.8 vs. 160.0±25.2, P<0.001). Perianal fistulas showed clinical response (drainage decreased by >50%), though none achieved remission. Entero-enteric fistulae showed complete healing. Mean body mass index improved from 15.6±3.1 to 18.9±1.9 kg/m2 at week 12 (P=0.003). Hemoglobin and serum albumin also improved from 8.2±1.1 g/dL and 2.8±0.3 g/dL at baseline to 12.6±0.6 g/dL and 3.6±0.5 g/dL post-EEN respectively (P<0.001 and P=0.006 respectively).
Conclusions EEN appears to be an effective and well tolerated therapy for induction of remission in anti-TNF refractory adult CD. More data from prospective trials with larger number of patients is required.
Pharmacogenetics in personalized treatment in pediatric patients with inflammatory bowel disease (IBD) Daniela Kosorínová, Pavlína Suchá, Zuzana Havlíčeková, Marek Pršo, Pavol Dvoran, Peter Bánovčin Česko-slovenská pediatrie.2024; 79(4): 213. CrossRef
Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy Frontline Gastroenterology.2024; : flgastro-2024-102749. CrossRef
Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn’s disease: A cohort study from northern India Arshdeep Singh, Chandan Kakkar, Shreya Garg, Kirti Arora, Vandana Midha, Ramit Mahajan, Satpal Singh Virk, Narender Pal Jain, Dharmatma Singh, Kriti Sood, Ashish Tripathi, Dhruv Gupta, Ishita Gupta Kaushal, Ritu Dhawan Galhotra, Kavita Saggar, Ajit Sood Indian Journal of Gastroenterology.2023; 42(5): 668. CrossRef
Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai Nutrition in Clinical Practice.2023; 38(6): 1282. CrossRef
Incidence and Prevalence of Inflammatory Bowel Disease across Asia Jihye Park, Jae Hee Cheon Yonsei Medical Journal.2021; 62(2): 99. CrossRef
Review of exclusive enteral therapy in adult Crohn’s disease Nikola Mitrev, Hin Huang, Barbara Hannah, Viraj Chandana Kariyawasam BMJ Open Gastroenterology.2021; 8(1): e000745. CrossRef
Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review Ji Young Chang, Jae Hee Cheon Precision and Future Medicine.2021; 5(4): 151. CrossRef
Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow Tadakazu Hisamatsu Intestinal Research.2020; 18(2): 139. CrossRef
Sun-Ho Lee, Kiju Chang, Ki Seok Seo, Yun Kyung Cho, Eun Mi Song, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
Intest Res 2020;18(2):192-199. Published online April 3, 2020
Background/Aims The use of complementary and alternative medicine (CAM) is a global phenomenon, including inflammatory bowel disease (IBD) patients. We aimed to assess the change in prevalence and patterns of CAM use, and attitudes towards CAM over an 8-year time interval (2006 vs. 2014) among IBD patients in Korea.
Methods A total of 221 IBD patients (CD=142, UC=79) were asked to complete a questionnaire regarding CAM at two time points: at enrollment (2006) and 8 years later (2014/2015).
Results The proportion of patients ever using CAM increased significantly from 60.2% in 2006 to 79.6% in 2014 (P<0.001), while the proportion of current CAM users increased slightly (35.7% to 38.0%, P=0.635); 21.7% used CAM consistently at both time points. The proportion of patients who felt CAM was less effective (P<0.001) and more expensive (P=0.04) than conventional treatments increased over time. Also, the proportion among ever CAM users who perceived a positive effect from CAM significantly decreased in 2014 compared to 2006 (P=0.004). Higher education (adjusted odds ratio [aOR], 2.10), prior side effects to conventional therapies (aOR, 2.23), and prior use of corticosteroids (aOR, 2.51) were associated with CAM use. Interestingly, use of CAM before IBD diagnosis (aOR, 2.73) was significantly associated with consistent CAM use.
Conclusions Although the attitudes toward CAM have become less favorable, the majority of IBD patients have experienced CAM with an overall increase of current CAM users over time. Moreover, more than half of current CAM users used CAM consistently over time.
Citations
Citations to this article as recorded by
A comparative analysis of complementary therapies use among patients attending diabetic clinics in Taiwan: 2007 vs. 2023 Hsiao-Yun Chang, Yu-Yao Huang, Chin-Jung Chung, Feng-Hsuan Liu BMC Complementary Medicine and Therapies.2023;[Epub] CrossRef
Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, Dong Il Park, Jong Pil Im, Chang Soo Eun, Hyuk Yoon, Byung Ik Jang, Haruhiko Ogata, Kayoko Fukuhara, Fumihito Hirai, Kazuo Ohtsuka, Jing Liu, Qian Cao Intestinal Research.2022; 20(2): 192. CrossRef
Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis Jae Song Kim, Min Jung Geum, Eun Sun Son, Yun Mi Yu, Jae Hee Cheon, Kyeng Hee Kwon Gut and Liver.2022; 16(5): 736. CrossRef
Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD) Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi Expert Review of Clinical Pharmacology.2021; 14(7): 865. CrossRef
Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence? Jae Myung Cha Intestinal Research.2020; 18(2): 141. CrossRef
Background/Aims Crohn’s disease (CD) primarily affects young female adults of reproductive age. Few studies have been conducted on this population’s ovarian reserve status. The aim of study was to investigate potential risk factors associated with low ovarian reserve, as reflected by serum anti-Müllerian hormone (AMH) in women of reproductive age with CD.
Methods This was a case-control study. Cases included 87 patients with established CD, and healthy controls were matched by age, height and weight in a 1:1 ratio. Serum AMH levels were measured by enzyme-linked immunosorbent assay.
Results The average serum AMH level was significantly lower in CD patients than in control group (2.47±2.08 ng/mL vs. 3.87±1.96 ng/mL, respectively, P<0.001). Serum AMH levels were comparable between CD patients and control group under 25 years of age (4.41±1.52 ng/mL vs. 3.49±2.10 ng/mL, P=0.06), however, serum AMH levels were significantly lower in CD patients over 25 years of age compared to control group (P<0.05). Multivariable analysis showed that an age greater than 25 (odds ratio [OR], 10.03; 95% confidence interval [CI], 1.90–52.93, P=0.007), active disease state (OR, 27.99; 95% CI, 6.13–127.95, P<0.001) and thalidomide use (OR, 15.66; 95% CI, 2.22–110.65, P=0.006) were independent risk factors associated with low ovarian reserve (serum AMH levels <2 ng/mL) in CD patients.
Conclusions Ovarian reserve is impaired in young women of reproductive age with CD. Age over 25 and an active disease state were both independently associated with low ovarian reserve. Thalidomide use could result in impaired ovarian reserve.
Citations
Citations to this article as recorded by
Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease Matteo Bramuzzo, Fabiola Giudici, Serena Arrigo, Paolo Lionetti, Giovanna Zuin, Claudio Romano, Francesco Graziano, Simona Faraci, Patrizia Alvisi, Sara Signa, Luca Scarallo, Stefano Martelossi, Grazia Di Leo Inflammatory Bowel Diseases.2024; 30(1): 20. CrossRef
Inhibin B and antiMüllerian hormone as surrogate markers of fertility in male and female Crohn’s disease patients: a case-control study Ana Gutiérrez, Roser Muñoz-Pérez, Pedro Zapater, Cristina Mira, Andrés Rodríguez, Laura Sempere-Robles, María Eugenia Torregrosa, Rocio Alfayate, Violeta Moreno-Torres, Lorena Bernal, Olivia Belén-Galipienso, Jose Ignacio Cameo, Paula Sirera, Belen Herrer Frontiers in Medicine.2024;[Epub] CrossRef
Factors associated with decreased ovarian reserve in Crohn's disease: A systematic review and meta‐analysis Arthur Foulon, Nicolas Richard, Camille Guichard, Clara Yzet, Coraline Breuval, Jean Gondry, Rosalie Cabry‐Goubet, Audrey Michaud, Mathurin Fumery Acta Obstetricia et Gynecologica Scandinavica.2024; 103(9): 1714. CrossRef
Serum anti-mullerian hormone, sex hormone, and nutrient levels in reproductive age women with celiac disease Ailifeire Tuerxuntayi, Tian Shi, Beiyao Gao, Yan Feng, Ting Li, Wenjia Hui, Shenglong Xue, Feng Gao Journal of Assisted Reproduction and Genetics.2024; 41(8): 2129. CrossRef
A Gender Perspective on Coloproctological Diseases: A Narrative Review on Female Disorders Paola De Nardi, Greta Giacomel, Simone Orlandi, Giulia Poli, Mauro Pozzo, Marcella Rinaldi, Antonella Veglia, Renato Pietroletti Journal of Clinical Medicine.2024; 13(20): 6136. CrossRef
Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis Lin Guo, Yi Liu, Jiansheng Li, Quan Liu, Bing Liu, Xuewen Shi Medicine.2023; 102(11): e33113. CrossRef
Inflammatory bowel disease in pregnancy and breastfeeding Max N. Brondfield, Uma Mahadevan Nature Reviews Gastroenterology & Hepatology.2023; 20(8): 504. CrossRef
Case report: A pregnant woman with Crohn disease who used ustekinumab to the 3rd trimester developed severe infection Peng Guo, Wulan Cao Medicine.2023; 102(48): e36253. CrossRef
Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities Reem Al-jabri, Panu Wetwittayakhlang, Peter L. Lakatos Journal of Clinical Medicine.2023; 12(23): 7343. CrossRef
General review of pregnancy in inflammatory bowel disease Elena Santos Pérez, Marta Calvo Moya Revista Española de Enfermedades Digestivas.2022;[Epub] CrossRef
Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy—A Narrative Review Camilla Ronchetti, Federico Cirillo, Noemi Di Segni, Martina Cristodoro, Andrea Busnelli, Paolo Emanuele Levi-Setti Nutrients.2022; 14(8): 1591. CrossRef
Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis Honghao Sun, Jiao Jiao, Feng Tian, Qing Liu, Jiansu Bian, Rongmin Xu, Da Li, Xiuxia Wang, Hong Shu eClinicalMedicine.2022; 50: 101517. CrossRef
Inflammatory Bowel Disease and Pregnancy Eugenia Shmidt, Marla C. Dubinsky American Journal of Gastroenterology.2022; 117(10S): 60. CrossRef
Reproductive Health in IBD Patients Sanket Patel, Haleh Vaziri Current Treatment Options in Gastroenterology.2021; 19(2): 237. CrossRef
Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study T. Koller, J. Kollerová, T. Hlavatý, B. Kadlečková, J. Payer Physiological Research.2021; : S69. CrossRef
THE ROLE OF IMMUNOGLOBULIN A IN THE INFLAMMATORY PROCESS INVOLVING NEUTROPHILS O.O. Prudnikov, I.M. Prudnikov, V.M. Tsyvkin, A.M. Smirnov, R.I. Yanchiy Fiziolohichnyĭ zhurnal.2021; 67(5): 44. CrossRef
Update on Pregnancy in Patients with IBD Rachel W. Winter, Sonia Friedman Current Treatment Options in Gastroenterology.2020; 18(3): 423. CrossRef
Background/Aims Crohn’s disease (CD) may involve the upper parts of the gastrointestinal (GI) tract including the esophagus, stomach, and duodenum. Clinical features of upper GI CD (UGICD) are not well characterized in the Gulf region. We therefore aimed to assess the prevalence and clinical characteristics of patients diagnosed with UGICD.
Methods We performed a retrospective analysis of all patients diagnosed with CD who underwent upper GI endoscopy between 2012 and 2017 at King Abdulaziz University Hospital, irrespective of age. Patients who had endoscopy of the upper GI tract at baseline and had histologically confirmed UGICD were included. Data on patients’ demographics, clinical characteristics, extraintestinal manifestations and complications were reviewed.
Results We identified 78 CD patients who underwent upper GI endoscopy from our medical records. The mean age was 17.2±8.7 years and 55.1% were males. Of the total, 19 out of 78 patients (24.4%) had histologically confirmed UGICD (3 esophageal, 16 gastric, and 9 duodenal), of which 52.6% were symptomatic. Disease distribution was ileal in 57.8%, colonic in 21.1% and ileo-colonic in 21.1%. A non-stricturing and non-penetrating phenotype was reported in 89.4%, stricturing in 5.3%, and penetrating in 5.3%. Perianal disease was found in 10.5%. UGICD was complicated by stricture formation in 2 patients (esophageal and gastric).
Conclusions The prevalence of UGICD is considered high among CD Saudi patients who undergo upper GI endoscopy at baseline, and is asymptomatic in 47.4% of patients. This reported prevalence is not dissimilar from reports originating from Western countries.
Citations
Citations to this article as recorded by
Les maladies inflammatoires chroniques intestinales (MICI) et tube digestif haut Denis Chatelain, Amine Moslemi, Axel Dreau, Marine Clement Annales de Pathologie.2023; 43(3): 192. CrossRef
Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park Clinical Endoscopy.2023; 56(2): 239. CrossRef
A systematic review and meta‐analysis of prevalence and clinical features of upper gastrointestinal (UGI) tract Crohn's disease in adults compared to non‐UGI types Babak Tamizifar, Peyman Adibi, Maryam Hadipour, Vahid Mohamadi JGH Open.2023; 7(5): 325. CrossRef
Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease Mahmoud H. Mosli, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Amr M. Khardaly, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Baward Saudi Journal of Gastroenterology.2023; 29(Suppl 1): S1. CrossRef
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease? Naoimh Herlihy, Roger Feakins United European Gastroenterology Journal.2022; 10(5): 451. CrossRef
Focal Active Brunner Gland Lobulitis: Ignored or Yet Undetected Sign of Crohn Duodenitis? Badr AbdullGaffar, Huda Quarishi Advances in Anatomic Pathology.2022;[Epub] CrossRef
Histopathologic Manifestations of Crohn Disease in Duodenal Endoscopy Biopsy: The Value of Different Patterns of Involvement of Brunner Glands Badr AbdullGaffar, Hoda Quraishi International Journal of Surgical Pathology.2021; 29(7): 710. CrossRef
“Is Focally Enhanced Active Inflammation of Brunner Glands a Sign of Crohn Duodenitis?” Badr AbdullGaffar, Hoda Quraishi International Journal of Surgical Pathology.2021; 29(8): 926. CrossRef
Systematic review with meta-analysis: The prevalence, risk factors and outcomes of upper gastrointestinal tract Crohn's disease Yip Han Chin, Cheng Han Ng, Snow Yunni Lin, Sneha Rajiv Jain, Gwyneth Kong, Jeffery Wei Heng Koh, Darren Jun Hao Tan, David Eng Hui Ong, Mark Dhinesh Muthiah, Choon Seng Chong, Fung Joon Foo, Rupert Leong, Webber Pak Wo Chan Digestive and Liver Disease.2021; 53(12): 1548. CrossRef
Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approach Luca Mastracci, Federica Grillo, Paola Parente, Elettra Unti, Serena Battista, Paola Spaggiari, Michela Campora, Luca Valle, Matteo Fassan, Roberto Fiocca Pathologica.2020; 112(3): 128. CrossRef
Background/Aims Intestinal fibrosis is a major complication of Crohn’s disease (CD). The profibrotic protein transforming growth factor-β (TGF-β) has been considered to be critical for the induction of the fibrotic program. TGF-β has the ability to induce not only the expression of extracellular matrix (ECM) including collagen, but also the production of plasminogen activator inhibitor-1 (PAI-1) that prevents enzymatic degradation of the ECM during the onset of fibrotic diseases. However, the significance of PAI-1 in the developing intestinal fibrosis has not been fully understood. In the present study, we examined the actual expression of PAI-1 in fibrotic legion of intestinal inflammation and its correlation with the abnormal ECM deposition.
Methods Chronic intestinal inflammation was induced in BALB/c mice using 8 repeated intrarectal injections of 2,4,6-trinitrobenzene sulfonic acid (TNBS). TM5275, a PAI-1 inhibitor, was orally administered as a carboxymethyl cellulose suspension each day for 2 weeks after the sixth TNBS injection.
Results Using a publicly available dataset (accession number, GSE75214) and TNBS-treated mice, we observed increases in PAI-1 transcripts at active fibrotic lesions in both patients with CD and mice with chronic intestinal inflammation. Oral administration of TM5275 immediately after the onset of intestinal fibrosis upregulated MMP-9 (matrix metalloproteinase 9) and decreased collagen accumulation, resulting in attenuation of the fibrogenesis in TNBS-treated mice.
Conclusions PAI-1-mediated fibrinolytic system facilitates collagen degradation suppression. Hence, PAI-1 inhibitor could be applied as an anti-fibrotic drug in CD treatment.
Citations
Citations to this article as recorded by
The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms Yuling Wang, Linke Jiao, Caoxia Qiang, Chen Chen, Zihuan Shen, Fan Ding, Lifei Lv, Tingting Zhu, Yingdong Lu, Xiangning Cui Biomedicine & Pharmacotherapy.2024; 171: 116116. CrossRef
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1 Abd Aziz Ibrahim, Taku Fujimura, Tomoko Uno, Tomoya Terada, Ken-ichi Hirano, Hiroyuki Hosokawa, Akio Ohta, Toshio Miyata, Kiyoshi Ando, Takashi Yahata Frontiers in Immunology.2024;[Epub] CrossRef
Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons Irene Mignini, Valentina Blasi, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco International Journal of Molecular Sciences.2024; 25(12): 6326. CrossRef
Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population José Alvaro Lomelí-Nieto, José Francisco Muñoz-Valle, José Eduardo Navarro-Zarza, Christian Johana Baños-Hernández, Jesús Alberto Gutierrez-Brito, Valeria Renteria-Cabrera, Eduardo Arturo Horta-Chávez, José Javier Morales-Núñez, Samuel García-Arellano, Is Life.2024; 14(9): 1056. CrossRef
PAI-1 siRNA-loaded biomimetic nanoparticles for ameliorating diminished ovarian reserve and inhibiting ovarian fibrosis Hua Guo, Chang Xiao, Xinshu Li, Jialing Li, Xue Chen, Bin liu, Rong Hu European Journal of Pharmacology.2024; : 176948. CrossRef
Metformin acts on miR-181a-5p/PAI-1 axis in stem cells providing new strategies for improving age-related osteogenic differentiation decline Guanhao Hong, Yulan Zhou, Shukai Yang, Shouquan Yan, Jiaxu Lu, Bo Xu, Zeyu Zhan, Huasheng Jiang, Bo Wei, Jiafeng Wang Stem Cells.2024;[Epub] CrossRef
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review Aya A. Touny, Balaji Venkataraman, Shreesh Ojha, Mauro Pessia, Veedamali S. Subramanian, Shamanth Neralagundi Hariharagowdru, Sandeep B. Subramanya Nutrients.2024; 16(21): 3633. CrossRef
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi Journal of Clinical Medicine.2023; 12(9): 3052. CrossRef
Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn’s Disease Seung Won Kim, Jae-Young Lee, Han Cheol Lee, Jae Bum Ahn, Ji Hyung Kim, I Seul Park, Jae Hee Cheon, Duk Hwan Kim Gut and Liver.2023; 17(6): 905. CrossRef
Revisiting fibrosis in inflammatory bowel disease: the gut thickens Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169. CrossRef
The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease Yuki Hayashi, Hiroshi Nakase Frontiers in Physiology.2022;[Epub] CrossRef
Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking Taylor J. Louis, Ahmad Qasem, Saleh A. Naser Frontiers in Immunology.2022;[Epub] CrossRef
ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis Ilaria Laudadio, Alex Bastianelli, Valerio Fulci, Claudia Carissimi, Eleonora Colantoni, Francesca Palone, Roberta Vitali, Elisa Lorefice, Salvatore Cucchiara, Anna Negroni, Laura Stronati International Journal of Molecular Sciences.2022; 23(18): 10261. CrossRef
Macrophages in intestinal fibrosis and regression Hui Yao, Guoyao Tang Cellular Immunology.2022; 381: 104614. CrossRef
Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker, Florian Rieder Expert Review of Gastroenterology & Hepatology.2021; 15(4): 401. CrossRef
Elevated expression of plasminogen activator inhibitor (PAI-1/SERPINE1) is independent from rs1799889 genotypes in arthrofibrosis Banu Bayram, Aaron R. Owen, Amel Dudakovic, Jacob W. Bettencourt, Afton K. Limberg, Mark E. Morrey, Joaquin Sanchez-Sotelo, Daniel J. Berry, Jean-Pierre A. Kocher, Andre J. van Wijnen, Matthew P. Abdel Meta Gene.2021; 28: 100877. CrossRef
Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease Muaad Abdulla, Thean Soon Chew Current Opinion in Gastroenterology.2021; 37(3): 275. CrossRef
Intestinal stricture in Crohn's disease: A 2020 update Xiao Xuan Lin, Yun Qiu, Xiao Jun Zhuang, Fen Liu, Xiao Min Wu, Min Hu Chen, Ren Mao Journal of Digestive Diseases.2021; 22(7): 390. CrossRef
Therapeutic applications of PAI-1 inhibitor for the treatment of hematological malignancies Takashi Yahata Japanese Journal of Thrombosis and Hemostasis.2020; 31(3): 310. CrossRef
Background/Aims We retrospectively analyzed Crohn’s disease (CD) patients with small intestinal strictures who underwent single-balloon enteroscopy (SBE) to ascertain whether prototype SBEs with a passive bending mechanism and high force transmission insertion tube had better insertability in the small intestine than a conventional SBE.
Methods Among 253 CD patients who underwent SBE, we identified 94 CD patients who had undergone attempted endoscopic balloon dilatation (EBD) for small intestinal stenosis for inclusion in this study. We analyzed whether the type of scope used for their initial procedure affected the cumulative surgery-free rate. For the insertability analysis, patients who underwent SBE at least twice were divided into 3 groups according to the type of scope used: conventional SBE only, prototype SBE only, and both conventional and prototype SBEs. For each group, depth of insertion, procedure time, and number of EBDs were compared in the same patient at different time points.
Results The success rate of EBD was 88.3%. The 5- and 10-year cumulative surgery-free rate was 75.7% and 72.8%, respectively. Cox regression analysis indicated that the factors contributing to surgery were long stricture (≥2 cm), EBD failure, and elevated Crohn’s Disease Activity Index, but not the type of scope used for EBD. The prototype SBEs significantly improved the depth of insertion (P=0.03, Wilcoxon’s signed-rank test).
Conclusions In CD patients with small intestinal stenosis, the prototype SBEs with a passive bending mechanism and high force transmission insertion tube did not improve long-term EBD outcome but did improve deep insertability. (Clinical Trial Registration No. UMIN000037102)
Citations
Citations to this article as recorded by
Role of Device-Assisted Enteroscopy in Crohn’s Disease Giulia Catassi, Clelia Marmo, Antonio Gasbarrini, Maria Elena Riccioni Journal of Clinical Medicine.2024; 13(13): 3919. CrossRef
Performance of Balloon-Assisted Enteroscopy for Non-ERCP Indications in Patients with Surgically Altered Gastrointestinal Anatomy Ji Hee Song, Seong Ran Jeon, Jin Su Kim, Bo-In Lee, Jin-Oh Kim, Han Hee Lee Digestive Diseases and Sciences.2023; 68(6): 2545. CrossRef
Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study Yuna Kim, Jae-Hyun Kim, Eun-Ae Kang, Soo-Jung Park, Jae-Jun Park, Jae-Hee Cheon, Tae-Il Kim, Jihye Park, Seong-Ran Jeon Diagnostics.2022; 12(4): 954. CrossRef
Intestinal stricture in Crohn's disease: A 2020 update Xiao Xuan Lin, Yun Qiu, Xiao Jun Zhuang, Fen Liu, Xiao Min Wu, Min Hu Chen, Ren Mao Journal of Digestive Diseases.2021; 22(7): 390. CrossRef
Factors Affecting Route Selection of Balloon-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study Dong Hoon Baek, Seonyeong Hwang, Chang Soo Eun, Seong Ran Jeon, Jinsu Kim, Eun Ran Kim, Dong-Hoon Yang, Hyun Joo Jang, Jong Pil Im, Soo Jung Park, Sung Hoon Jung Diagnostics.2021; 11(10): 1860. CrossRef
Background/Aims Opioid-induced bowel dysfunction includes nausea, vomiting, constipation and abdominal distension. We describe patients presenting with gastrointestinal (GI) ulcers and ulcerated strictures secondary to opioid abuse, an entity not well described in literature.
Methods This retrospective observational study included patients with opioid abuse gastroenteropathy presenting to Dayanand Medical College and Hospital, Ludhiana, India between January 2013 and December 2018. Opioid abuse gastroenteropathy was defined as gastric or small bowel ulcers and ulcerated strictures in patients abusing opioids, where all other possible etiologies of GI ulcers/strictures were excluded. Clinical, biochemical, endoscopic, radiological and histological parameters as well as response to treatment were assessed.
Results During the study period, 20 patients (mean age, 38.5±14.2 years; 100% males) were diagnosed to have opioid induced GI ulcers and/or ulcerated strictures. The mean duration of opioid consumption was 6.2±3.4 years. The mean duration of symptoms at presentation was 222.1±392.3 days. Thirteen patients (65%) had gastroduodenal involvement, 6 (30%) had a jejunoileal disease and 1 (5%) had an ileocecal stricture. Two patients (10%) presented with upper GI bleeding, 11 (55%) had features of gastric outlet obstruction and 7 (35%) presented with small bowel obstruction. Abdominal pain and iron deficiency anemia were the most common presentations. Only 1 patient (5%) responded to proton pump inhibitors, 3 (15%) had a lasting response to endoscopic balloon dilatation, while all other (80%) required surgical intervention.
Conclusions Opioid abuse gastroenteropathy presents as ulcers and ulcerated strictures which respond poorly to medical management and endoscopic balloon dilatation. A majority of these cases need surgical intervention.
Citations
Citations to this article as recorded by
Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding Mohsen Masoodi, Mohammad Sabzikarian, Nikta Masoodi, Saeed Farhadi, Gholam Reza Rezamand, Seidamir Pasha Tabaeian, Atefeh Talebi, Farimah Fayyaz BMC Gastroenterology.2024;[Epub] CrossRef
Cryptogenic multifocal ulcerous stenosing enteritis: A ray of light on the umbra of the dark continent Mithu Bhowmick, Vishal Sharma Indian Journal of Gastroenterology.2024; 43(6): 1082. CrossRef
Adult‐onset megacolon with focal hypoganglionosis: A detailed phenotyping and prospective cohort study Jiyoung Yoon, Kee Wook Jung, Nam Seok Ham, Jihun Kim, Yoon Suh Do, Seon Ok Kim, Sang Hyun Choi, Dong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Yong Sik Yoon, Chan Wook Kim, Chang Sik Yu, Hwoon‐Yong Jung, S Neurogastroenterology & Motility.2023;[Epub] CrossRef
Endogenous opiates and behavior: 2020 Richard J. Bodnar Peptides.2022; 151: 170752. CrossRef